I think this comment paired with the fact Neuren has stated publicly they aren't intending to sell the drugs themselves should satisfy people who want a return in the medium term compared to the long term. It flags that a transaction could occur anytime if the buyer pays the right price and they aren't going to be selfish and keep the company existing so they have a job - they will sell to the highest bidder if that's the best thing for shareholders rather than try a build a sales force, or do something else they aren't set up to do. I think this is an incredibly important point and the fact the NNZ-2591 trials will be 3 months long means that this could all happen rather quickly, where we see another 10x+ uplift like we did from Trof when we were trading in the $1-3 (post consolidation) range for many years until the share price went bizzerk
Note: 3 months is the trial length (after recruitment) - the entire process can take longer but we can get an offer after results but before a NDA and/or approval.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)